Significantly high GM-CSF, IL-2, IL-3, IL-4, IL-6, MCP-1, IFN-γ, and RANTES levels have been demonstrated in preclinical and clinical SCD (32, 46, 47). This evidence concerns the gene CSF2 and Schnyder corneal dystrophy.